CN116236550A - Light traditional Chinese medicine formula preparation for treating novel coronavirus infection and preparation method thereof - Google Patents
Light traditional Chinese medicine formula preparation for treating novel coronavirus infection and preparation method thereof Download PDFInfo
- Publication number
- CN116236550A CN116236550A CN202310070991.XA CN202310070991A CN116236550A CN 116236550 A CN116236550 A CN 116236550A CN 202310070991 A CN202310070991 A CN 202310070991A CN 116236550 A CN116236550 A CN 116236550A
- Authority
- CN
- China
- Prior art keywords
- coronavirus infection
- light
- chinese medicine
- traditional chinese
- novel coronavirus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000001528 Coronaviridae Infections Diseases 0.000 title claims abstract description 44
- 239000003814 drug Substances 0.000 title claims abstract description 37
- 238000002360 preparation method Methods 0.000 title claims abstract description 23
- 241001264174 Cordyceps militaris Species 0.000 claims abstract description 8
- 244000042430 Rhodiola rosea Species 0.000 claims abstract description 8
- 235000003713 Rhodiola rosea Nutrition 0.000 claims abstract description 8
- 241001092371 Bergenia Species 0.000 claims abstract description 7
- 244000130270 Fagopyrum tataricum Species 0.000 claims abstract description 7
- 235000014693 Fagopyrum tataricum Nutrition 0.000 claims abstract description 7
- 239000000843 powder Substances 0.000 claims abstract description 7
- 239000004698 Polyethylene Substances 0.000 claims abstract description 4
- 238000004806 packaging method and process Methods 0.000 claims abstract description 4
- 239000004033 plastic Substances 0.000 claims abstract description 4
- 229920003023 plastic Polymers 0.000 claims abstract description 4
- -1 polyethylene Polymers 0.000 claims abstract description 4
- 229920000573 polyethylene Polymers 0.000 claims abstract description 4
- 239000002994 raw material Substances 0.000 claims abstract description 4
- 238000007789 sealing Methods 0.000 claims abstract description 4
- 241001428166 Eucheuma Species 0.000 claims description 8
- 244000167230 Lonicera japonica Species 0.000 claims description 8
- 235000017617 Lonicera japonica Nutrition 0.000 claims description 8
- 244000018633 Prunus armeniaca Species 0.000 claims description 7
- 235000009827 Prunus armeniaca Nutrition 0.000 claims description 7
- 239000008187 granular material Substances 0.000 claims description 6
- 239000011812 mixed powder Substances 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 4
- 239000002775 capsule Substances 0.000 claims description 3
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 3
- 229940124531 pharmaceutical excipient Drugs 0.000 claims description 3
- 239000006187 pill Substances 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 2
- 238000009472 formulation Methods 0.000 claims 1
- 208000024891 symptom Diseases 0.000 abstract description 19
- 201000009240 nasopharyngitis Diseases 0.000 abstract description 18
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 244000025254 Cannabis sativa Species 0.000 abstract 1
- 238000010298 pulverizing process Methods 0.000 abstract 1
- 238000007873 sieving Methods 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 206010011224 Cough Diseases 0.000 description 21
- 206010062717 Increased upper airway secretion Diseases 0.000 description 15
- 208000026435 phlegm Diseases 0.000 description 15
- 206010061428 decreased appetite Diseases 0.000 description 13
- 208000022531 anorexia Diseases 0.000 description 12
- 210000004072 lung Anatomy 0.000 description 11
- 229940079593 drug Drugs 0.000 description 9
- 230000007803 itching Effects 0.000 description 9
- 208000002193 Pain Diseases 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 206010037660 Pyrexia Diseases 0.000 description 7
- 238000011084 recovery Methods 0.000 description 7
- 208000003251 Pruritus Diseases 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 210000000214 mouth Anatomy 0.000 description 6
- 206010063659 Aversion Diseases 0.000 description 5
- 206010028748 Nasal obstruction Diseases 0.000 description 5
- 238000003745 diagnosis Methods 0.000 description 5
- 208000017574 dry cough Diseases 0.000 description 5
- 206010016256 fatigue Diseases 0.000 description 5
- 230000001717 pathogenic effect Effects 0.000 description 5
- 238000005728 strengthening Methods 0.000 description 5
- 208000011580 syndromic disease Diseases 0.000 description 5
- 206010002653 Anosmia Diseases 0.000 description 4
- 206010010741 Conjunctivitis Diseases 0.000 description 4
- 241000711573 Coronaviridae Species 0.000 description 4
- 206010015958 Eye pain Diseases 0.000 description 4
- 206010019233 Headaches Diseases 0.000 description 4
- 206010050515 Hyposmia Diseases 0.000 description 4
- 206010039101 Rhinorrhoea Diseases 0.000 description 4
- 206010047700 Vomiting Diseases 0.000 description 4
- 231100000869 headache Toxicity 0.000 description 4
- 235000019559 hyposmia Nutrition 0.000 description 4
- 208000010753 nasal discharge Diseases 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 208000003556 Dry Eye Syndromes Diseases 0.000 description 3
- 206010013774 Dry eye Diseases 0.000 description 3
- 206010052140 Eye pruritus Diseases 0.000 description 3
- 206010024642 Listless Diseases 0.000 description 3
- 208000000112 Myalgia Diseases 0.000 description 3
- 230000036760 body temperature Effects 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 208000017971 listlessness Diseases 0.000 description 3
- 208000015001 muscle soreness Diseases 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 206010028813 Nausea Diseases 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- 206010040925 Skin striae Diseases 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 230000003387 muscular Effects 0.000 description 2
- 230000008693 nausea Effects 0.000 description 2
- 101150076076 64 gene Proteins 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 240000004972 Bergenia crassifolia Species 0.000 description 1
- 235000014785 Bergenia crassifolia Nutrition 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 241001523681 Dendrobium Species 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 240000006021 Solidago canadensis Species 0.000 description 1
- 235000003657 Solidago canadensis Nutrition 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 229940124600 folk medicine Drugs 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 230000020169 heat generation Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 230000009967 tasteless effect Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/066—Clavicipitaceae
- A61K36/068—Cordyceps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/41—Crassulaceae (Stonecrop family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
A light traditional Chinese medicine formula preparation for treating novel coronavirus infection and a preparation method thereof are provided, wherein the raw materials and the weight ratio are respectively as follows: 2 parts of night hansu, kylin grass respectively, 1 part of Chinese fevervine herb, tartary buckwheat, rhodiola rosea, honeysuckle leaves, bergenia, and 0.75 part of Cordyceps militaris respectively. Pulverizing to above 120 mesh in pulverizer, and sieving with seventh sieve; packaging 6g of the powder into polyethylene plastic bags for sealing. The invention has positive significance for developing traditional Chinese medicine and enriching traditional Chinese medicine, can be widely used for treating the symptoms of light and common cold wind-cold dampness and dryness caused by the novel coronavirus infection, adds an effective, convenient, safe, economical and suitable therapeutic medicament for treating the symptoms of light and common cold wind-cold dampness and dryness caused by the novel coronavirus infection, has a lower price of , and provides a novel safe, economical, convenient and suitable way for selecting the medicament for patients suffering from the symptoms of light and common cold wind-cold dampness and dryness caused by the novel coronavirus infection.
Description
Technical Field
The invention relates to a light traditional Chinese medicine formula preparation for treating novel coronavirus infection and a preparation method thereof, belonging to the field of traditional Chinese medicine formula preparation.
Background
The folk medicine is a medical treasury produced in the process of long-term fight against diseases of Chinese nations, is an important component of the traditional Chinese medicine resources of China, and can be used for developing a new medicine formula for treating common diseases, frequently-occurring diseases, difficult diseases and the like. The novel coronavirus infection is a very infectious disease, and the clinical manifestations of the novel coronavirus infection are mainly aversion to cold and fever, muscle soreness, dry cough, cough with little phlegm, phlegm sticky and difficult to get, pharyngalgia, itching throat, light taste and tasteless or anorexia, anorexia and hypodynamia, listlessness, diarrhea, nasal obstruction and nasal discharge or even hypoolfaction, eye pain and itching or conjunctivitis. Wind and cold are combined to attack lung and defensive qi, so that aversion to cold, nasal obstruction, running nose or even hyposmia are caused, and heat is caused by depression to transform into heat, so that fever and pharyngalgia are caused; wind-cold with dampness, pathogenic factors attacking the muscle and skin striae, which can cause muscular soreness, damp obstruction of middle energizer, poor appetite, debilitation, listlessness, diarrhea, nausea and emesis; wind-cold with dryness, pathogenic qi affecting the lung or resolving heat and burning lung-fluid and promoting the production of internal dryness causing lung failing to disperse and descend, dry cough, cough with little phlegm, sticky phlegm and difficult pain and itching throat; wind-cold-dampness invading liver meridian, it is manifested as eye pain, itching and dry eyes or conjunctivitis. The current folk traditional Chinese medicine medicines for treating the symptoms of light and common cold wind-cold dampness and dryness of the novel coronavirus infection are relatively few, and aiming at the current situation, the novel traditional Chinese medicine medicines with different compatibility for treating the symptoms of light and common cold wind-cold dampness and dryness of the novel coronavirus infection are explored and developed, and a novel way for selecting the medicines for treating the symptoms of light and common cold wind-cold dampness and dryness of the novel coronavirus infection is provided.
Disclosure of Invention
The invention aims to solve the technical problem of providing a new way for selecting medicines for treating the symptoms of novel coronavirus infection, light weight and common cold wind-cold dampness.
In order to solve the technical problems, the invention adopts the following technical scheme:
the light traditional Chinese medicine formula preparation for treating the novel coronavirus infection comprises the following raw materials in parts by weight: 2 parts of night cold threo, 2 parts of eucheuma, 1 part of Chinese fevervine, 1 part of tartary buckwheat, 1 part of rhodiola rosea, 1 part of lonicera japonica leaves, 1 part of bergenia, 1 part of cordyceps militaris and 0.75 part of bitter apricot kernel.
The preparation method of the light traditional Chinese medicine formula preparation for treating the novel coronavirus infection comprises the following steps:
step one: 2 parts of night hansu, 2 parts of eucheuma, 1 part of Chinese fevervine, 1 part of tartary buckwheat, 1 part of rhodiola rosea, 1 part of lonicera japonica, 1 part of bergenia, 1 part of cordyceps militaris and 0.75 part of bitter apricot kernel are put into a pulverizer to be pulverized into more than 120 meshes, and the mixture powder is obtained through a seventh sieve for standby;
step two: and (3) subpackaging 6g of the mixed powder obtained in the step one per small bag, and packaging the subpackaged powder into polyethylene plastic bags for sealing.
The mixed powder is matched with corresponding pharmaceutical excipients to be prepared into capsules, tablets, pills, medicinal granules and granules, and each bag is packaged into 6 g.
The formula preparation adopting the traditional Chinese medicine has the beneficial effects that:
the invention has positive significance for developing and enriching traditional Chinese medicine, can be widely used for treating the novel coronavirus infection with light weight and common cold wind-cold dampness and dryness, adds effective, convenient, safe, economical and suitable treatment medicaments for treating the novel coronavirus infection with light weight and common cold wind-cold dampness and dryness, has the characteristics of good curative effect and is convenient to store and transport; the formula is a plurality of Chinese herbal medicines from folk, so that the use of various traditional Chinese medicine and medical institutions is less, and the medicine sources are rich and have a certain guarantee. The price is lower , and a novel safe, economical, convenient and proper way for selecting and using medicines is provided for patients with novel coronavirus infection with light and common cold and wind-cold dampness.
Detailed Description
The present invention is described in further detail below:
the light traditional Chinese medicine formula preparation for treating the novel coronavirus infection comprises the following raw materials in parts by weight: 2 parts of night cold threo, 2 parts of eucheuma, 1 part of Chinese fevervine, 1 part of tartary buckwheat, 1 part of rhodiola rosea, 1 part of lonicera japonica leaves, 1 part of bergenia, 1 part of cordyceps militaris and 0.75 part of bitter apricot kernel.
The preparation method of the light traditional Chinese medicine formula preparation for treating the novel coronavirus infection comprises the following steps:
step one: 2 parts of night hansu, 2 parts of eucheuma, 1 part of Chinese fevervine, 1 part of tartary buckwheat, 1 part of rhodiola rosea, 1 part of lonicera japonica, 1 part of bergenia, 1 part of cordyceps militaris and 0.75 part of bitter apricot kernel are put into a pulverizer to be pulverized into more than 120 meshes, and the mixture powder is obtained through a seventh sieve for standby;
step two: and (3) subpackaging 6g of the mixed powder obtained in the step one per small bag, and packaging the subpackaged powder into polyethylene plastic bags for sealing.
The mixed powder is matched with corresponding pharmaceutical excipients to be prepared into capsules, tablets, pills, medicinal granules and granules, and each bag is packaged into 6 g.
The traditional Chinese medicine formula preparation has the effects of relieving exterior syndrome, clearing interior, strengthening spleen, reducing phlegm, moistening lung and relieving cough, and is used for patients who meet the requirements of the novel coronavirus infection diagnosis and treatment scheme (tenth trial edition) of light coronavirus infection and common cold wind-cold dampness and dryness. Symptoms are aversion to cold and fever (body temperature <38.5 ℃), muscle soreness, dry cough, cough with little phlegm, difficult phlegm, sore throat, itching throat, pale mouth or anorexia, anorexia and debilitation, nasal obstruction and nasal discharge or even hyposmia, red or pale red tongue, yellow greasy or white greasy coating, and superficial and tight or rapid pulse.
The usage amount is as follows: children and adults over 12 years old take 6-9 g each time, and children of 6-12 years old take 3-6g each time, 3 times daily, and take after meals. If the patients with eye pain, itching and dry eyes or conjunctivitis take the preparation 6-9 g by soaking 10g of chrysanthemum and dendrobium respectively in water, and taking the preparation after meals. Contraindications: forbidden for pregnant women, the new coronavirus infection diagnosis and treatment scheme (tenth edition of trial) is serious, and the medicine is cautiously used for medium and serious types of women with body temperature of more than 38.5 ℃ and fever of more than 3 days, patients with target organ injury of basic diseases, patients with poor control of basic diseases and infants, and the new coronavirus infection diagnosis and treatment scheme (tenth edition of trial).
The novel coronavirus infection is light and the common cold is cold with dampness, and the symptoms of dryness are caused by the combination of wind and cold, so that the symptoms of aversion to cold, nasal obstruction, nasal discharge or even hyposmia are caused, and the symptoms of heat generation and pharyngalgia are caused by depression; wind-cold with dampness, pathogenic factors attacking the muscle and skin striae, with symptoms of muscular soreness, headache, and damp obstruction of middle energizer, with symptoms of pale mouth, inappetence, debilitation, listlessness, diarrhea, nausea, and emesis; wind-cold with dryness, pathogenic qi affecting the lung or resolving heat and burning lung-fluid and promoting the production of internal dryness causing lung failing to disperse and descend, dry cough, cough with little phlegm, sticky phlegm and difficult pain and itching throat; wind-cold-dampness invading liver meridian, it is manifested as eye pain, itching and dry eyes or conjunctivitis. The night cold and the threo are used as monarch drugs for relieving exterior syndrome, dispelling cold, dispelling wind, relieving pain, warming middle-jiao, invigorating stomach and eliminating pathogenic factors; the eucheuma (Solidago canadensis) has the functions of clearing heat, detoxicating, eliminating dampness and clearing away internal heat, and modern pharmacology proves that the eucheuma has the pharmacological actions of easing pain, relieving cough, eliminating phlegm, resisting oxidation and resisting inflammation, and is used as a ministerial drug; the Chinese fevervine herb stomach strengthening and digestion promoting, phlegm reducing and cough relieving, heat clearing and detoxicating, pain relieving and auxiliary improvement of fever, pharyngalgia, cough and expectoration, headache and body pain caused by the novel coronavirus, oral cavity weakness or anorexia, anorexia and fatigue, nausea and vomiting caused by the novel coronavirus, the Chinese fevervine herb stomach strengthening and digestion promoting, heat clearing and detoxicating, pus expelling and stasis removing and auxiliary improvement of fever, pharyngalgia, cough and expectoration, headache and body pain, oral cavity weakness or anorexia, anorexia and fatigue, fatigue and fatigue caused by the novel coronavirus, the rhodiola rosea spleen strengthening and qi benefiting, lung heat clearing and cough relieving, blood activating and stasis removing auxiliary improvement of cough and phlegm, headache and body pain, oral cavity weakness or anorexia, anorexia and fatigue, nausea and vomiting caused by the novel coronavirus, the Chinese febrile herb has the functions of resisting fatigue and anoxia, and the three medicines all have the functions of strengthening spleen to promote the growth of gold, promote the diet and ensure the nutrition of human body and achieve the effect of improving immunity; the lonicera japonica leaves have the effects of clearing heat and detoxicating to improve depression and transform heat, and the modern pharmacology proves that the lonicera japonica leaves have good antiviral effect; bergenia crassifolia has the effects of moistening lung and relieving cough and moistening dryness; cordyceps militaris has effects of invigorating lung and kidney, relieving cough and stopping bleeding, and improving immunity; bitter apricot kernel, semen Armeniacae amarum moistens and relieves cough and asthma, enters the lung meridian and leads to the meridian. The medicines are used together to relieve exterior syndrome, clear interior, invigorate spleen, resolve phlegm, moisten lung and relieve cough, and are used for patients who are in line with the symptoms of light coronavirus infection and common cold wind-cold dampness and dryness in the diagnosis and treatment scheme of coronavirus infection (tenth edition of trial). Symptoms are aversion to cold and fever (body temperature <38.5 ℃), muscle soreness, dry cough, cough with little phlegm, difficult phlegm, sore throat, itching throat, pale mouth or anorexia, anorexia and debilitation, nasal obstruction and nasal discharge or even hyposmia, red or pale red tongue, yellow greasy or white greasy coating, and superficial and tight or rapid pulse.
The traditional Chinese medicine formula preparation is used for treating the symptoms of light and common cold wind-cold dampness, the treatment course is 5-7 days, the curative effect is observed after 7-10 days, the symptoms disappear to be healed, the symptoms are improved or reduced to be effective, and the symptoms are not improved or reduced to be ineffective, wherein 56 patients suffering from light and common cold wind-cold dampness are treated, 51 cases of the cure and effective patients are treated, and the effective rate is 91%; 23 patients with common cold with dampness and dryness are treated, 22 cases with cure and effectiveness are treated, and the effective rate is 95%; the following typical cases are detailed:
age diagnosis curative effect for name, sex and age
Light recovery from new coronavirus infection in men 40
Korean 47 novel coronavirus infection is light and effective
course-Male 57 novel light recovery from coronavirus infection
Novel 64-gene coronavirus infection light cure
Male 65 novel light recovery from coronavirus infection
Light cure of new type coronavirus infection for men 39
Light and effective coronavirus infection of Zhang Xnu 87
Light cure of new type 36 coronavirus infection
Light recovery from new coronavirus infection for men 12
Light cure of novel coronavirus infection in men 65
King-male 38 novel coronavirus infection light-duty efficacy
Light recovery from new type coronavirus infection for male 55
Deng 55 novel coronavirus infection light cure
Man 39 common cold wind-cold dampness syndrome recovery
Hu 61 common cold wind-cold dryness syndrome recovery
Plum 41 new coronavirus infection is slightly ineffective.
Claims (3)
1. A light traditional Chinese medicine formula preparation for treating novel coronavirus infection is characterized in that: the raw materials and the weight ratio are respectively as follows: 2 parts of night cold threo, 2 parts of eucheuma, 1 part of Chinese fevervine, 1 part of tartary buckwheat, 1 part of rhodiola rosea, 1 part of lonicera japonica leaves, 1 part of bergenia, 1 part of cordyceps militaris and 0.75 part of bitter apricot kernel.
2. A preparation method of a novel light traditional Chinese medicine formula preparation for treating coronavirus infection is characterized by comprising the following steps: it comprises the following steps:
step one: 2 parts of night hansu, 2 parts of eucheuma, 1 part of Chinese fevervine, 1 part of tartary buckwheat, 1 part of rhodiola rosea, 1 part of lonicera japonica, 1 part of bergenia, 1 part of cordyceps militaris and 0.75 part of bitter apricot kernel are put into a pulverizer to be pulverized into more than 120 meshes, and the mixture powder is obtained through a seventh sieve for standby;
step two: and (3) subpackaging 6g of the mixed powder obtained in the step one per small bag, and packaging the subpackaged powder into polyethylene plastic bags for sealing.
3. The method of preparing a light-duty traditional Chinese medicine formulation for treating novel coronavirus infection according to claim 2, wherein: the mixed powder is matched with corresponding pharmaceutical excipients to be prepared into capsules, tablets, pills, medicinal granules and granules, and each bag is packaged into 6 g.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202310070991.XA CN116236550A (en) | 2023-02-07 | 2023-02-07 | Light traditional Chinese medicine formula preparation for treating novel coronavirus infection and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202310070991.XA CN116236550A (en) | 2023-02-07 | 2023-02-07 | Light traditional Chinese medicine formula preparation for treating novel coronavirus infection and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN116236550A true CN116236550A (en) | 2023-06-09 |
Family
ID=86632441
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202310070991.XA Pending CN116236550A (en) | 2023-02-07 | 2023-02-07 | Light traditional Chinese medicine formula preparation for treating novel coronavirus infection and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN116236550A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112089805A (en) * | 2020-10-20 | 2020-12-18 | 贵州理工学院 | Application of herba Polygoni Multiflori radix volatile oil in preparing medicine and daily chemical product |
| CN113476523A (en) * | 2020-02-04 | 2021-10-08 | 石家庄以岭药业股份有限公司 | Application of traditional Chinese medicine composition in preparation of medicine for improving fever, cough and weakness of novel coronavirus infected pneumonia patients |
-
2023
- 2023-02-07 CN CN202310070991.XA patent/CN116236550A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113476523A (en) * | 2020-02-04 | 2021-10-08 | 石家庄以岭药业股份有限公司 | Application of traditional Chinese medicine composition in preparation of medicine for improving fever, cough and weakness of novel coronavirus infected pneumonia patients |
| CN112089805A (en) * | 2020-10-20 | 2020-12-18 | 贵州理工学院 | Application of herba Polygoni Multiflori radix volatile oil in preparing medicine and daily chemical product |
Non-Patent Citations (1)
| Title |
|---|
| 许金国；等: "加拿大一枝黄花与一枝黄花解热镇痛抗炎作用比较", 《辽宁中医药大学学报》, vol. 13, no. 2 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103055260A (en) | Traditional Chinese medicine composition for treating ulcerative colitis and preparation method thereof | |
| CN106361993A (en) | Medicinal composition for preventing and treating gastric mucosal lesion and preparation method of medicinal composition | |
| CN104825778A (en) | Traditional Chinese medicine composition for treating calf pneumonia | |
| CN111588828A (en) | Chinese medicinal preparation for treating new coronavirus and viral diseases, and its preparation method | |
| CN102872368B (en) | Chinese medicine acupoint application preparation for purging fire for removing toxin | |
| CN116236550A (en) | Light traditional Chinese medicine formula preparation for treating novel coronavirus infection and preparation method thereof | |
| CN1931262B (en) | Common cold treating Chinese medicine preparation | |
| CN103285162A (en) | Chinese medicine composition for reinforcing kidney to strengthen yang and preparation method thereof | |
| CN113144141A (en) | A Chinese medicinal composition for treating cough | |
| CN111529579A (en) | A Chinese medicinal composition for relieving hangover and treating alcoholic liver | |
| CN105796746B (en) | Traditional Chinese medicine for preventing and treating recurrent upper respiratory tract infection | |
| CN103550618A (en) | Medicine for preventing and treating infectious cold | |
| CN102895505B (en) | Medicine for treating dental caries toothache | |
| CN106491692A (en) | A kind of coldrex | |
| CN103285116B (en) | Traditional Chinese medicine preparation for treating influenza of infant | |
| CN101810741A (en) | Chinese medicament preparation for treating upper respiratory tract infection | |
| CN100457177C (en) | Chinese medicinal health-care preparation for cloaring lung, supplementing kidney | |
| CN101028352A (en) | Chinese-medicinal preparation for treating ischiodynia | |
| CN116115681A (en) | Formula and method for preparing medicament for treating tonsillitis | |
| CN105381351A (en) | Traditional Chinese medicine for treating infantile asthma caused by lung qi obstruction | |
| CN116983357A (en) | Tibetan medicine composition for treating influenza and viral hepatitis as well as preparation method and application thereof | |
| CN113842446A (en) | Traditional Chinese medicine composition for preventing and treating influenza | |
| CN104491662A (en) | Traditional Chinese preparation used for treating initial measles | |
| CN112494615A (en) | Traditional Chinese medicine composition, preparation method thereof, oral medicament and application | |
| CN100571762C (en) | The ichthyotic Chinese medicine preparation of a kind of treatment |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |